22 February 2022 · Transcribing is not the preferred option for medicines administration and the alternatives should be considered before committing to transcribing.
16 March 2021 · Medicines with RMM may not be suitable for inclusion within Patient Group Directions (PGDs). If used, the RMM must be stated within the PGD.
24 January 2022 · The main legal mechanisms used to supply and/or administer medicines are explained and considerations suggested for the most appropriate option(s)
9 September 2020 · This article provides advice on the legal considerations required when considering mixing medicines to be supplied or administered under a PGD
22 February 2022 · Consideration needs to be given to the risk factors particularly associated with transcribing in non-acute settings with healthcare input
8 January 2020 · A legal position summary regarding the sale, supply or administration of off-label/unlicensed products under Schedule 17 of the Human Medicines Regulations 2012